Investors

Stock
Information

MEDINCELL EURONEXT ELIGIBLE PME PEA

Listed on
EURONEXT PARIS / B COMPARTMENT
ISIN code / Ticker
FR0004065605 / MEDCL
Number of shares (March 31, 2022)
25,143,553
Liquidity Provider
KEPLER CHEUVREUX
Analysts
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF

Download our latest corporate presentation

Share price 20.05.2022 | 17:35 (Paris time)
5.86 €1.74%
Opening5.86 €
Previous closing 5.76 €
Shares traded 9.6 k

Investors

Events &
Presentations

Annual results Videoconference
June 14, 2022 at 7.30pm CEST

Participate

June 14, 2022

MedinCell
Annual results 2021-2022 (Apr. 2021 > Mar. 2022)

September 08, 2022

MedinCell
2022 General Meeting

December 06, 2022

MedinCell
Half-Year results
(Apr. > Sept. 2022)

PREVIOUS EVENTS

December 08, 2021

Videoconference • Half Year results

Replay

Transcript Presentation

November 02, 2021

Videoconference • mdc-IRM Phase 3 results

Replay

Transcript

September 01, 2021

Video conference • Portfolio update

Replay

Transcript Presentation

June 16, 2021

Video Conference • Annual results

Replay

Transcript Presentation

December 09, 2020

Video Conference • Half year results

Replay

Transcript

June 04, 2020

Video Conference • Annual results

Replay

Transcript

April 23, 2020

Video Conference • Adapt and overcome to the Covid-19 crisis

Replay

Transcript Presentation

December 03, 2019

Audio conference • Half year results

Replay

Transcript Presentation

June 04, 2019

Audio Conference • Annual results

Replay

Transcript Presentation

December 03, 2018

Audio Conference • Half year results

Replay

Transcript Presentation

Session en français

Rendez-vous le mardi 14 juin à 18h30 (CEST) pour une vidéoconférence dédiée aux résultas annuel 2021-2022

English session

On Tuesday 14, June at 7.30 pm (CEST) participate in our videoconference dedicated to our Financial year 2021-2022 results

INVESTORS

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

Investors

Documentation

Investors

General
Meeting

September 2021
September 2020
December 2020
September 2019

September 2021

Investors

Contacts

MedinCell

Head of Communication / IR

David Heuzé

david.heuze@medincell.com

+33 (0)6 83 25 21 86

MedinCell

Senior Communications Officer

Nicolas Gourgues

nicolas.gourgues@medincell.com

Investor Relations

NewCap

Louis-Victor Delouvrier & Mathilde Bohin

medincell@newcap.eu

+33 (0)1 44 71 94 94

Media

NewCap

Nicolas Merigeau

medincell@newcap.eu

+33 (0)1 44 71 94 94

CONTACT

  • This field is for validation purposes and should be left unchanged.